Ha-Nee Kwon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ha-Nee Kwon has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Sung-Chan Shin
College of Medicine, Pusan National Universtiy and Biomedical Research Institute, Pusan National University Hospital, Republic of Korea
9 shared publications - Yong-Il Cheon
Department of Otorhinolaryngology-Head and Neck Surgery and Biomedical Research Institute Pusan National University Hospital Busan Korea
7 shared publications - Byung-Joo Lee
Department of Otorhinolaryngology-Head and Neck Surgery and Biomedical Research Institute Pusan National University Hospital Busan Korea
6 shared publications - Se-Joon Oh
Department of Otorhinolaryngology, Pusan National University School of Medicine, Busan, Korea
4 shared publications - Gi Cheol Park
Department of Otolaryngology—Head and Neck Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Republic of Korea
2 shared publications - Hanaro Park
Department of Otorhinolaryngology-Head & Neck Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by The Busan, Ulsan, Gyeoungnam Branch of The Korean Society of Otolaryngology in Journal of Clinical Otolaryngology
- Vol. 37 (2) , 23-30
Thyroid Radiofrequency Ablation: Principles and Practice
- 30 June 2026
- Published by The Busan, Ulsan, Gyeoungnam Branch of The Korean Society of Otolaryngology in Journal of Clinical Otolaryngology
- Vol. 37 (2) , 23-30
Open AccessThyroid Radiofrequency Ablation: Principles and Practice
- Open Access
- 29 June 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (11) , 4981-4990
Effects of Ferrostatin‐1 on Vocal Folds in Aging Rats
Objective: Age‐related vocal fold degeneration is characterized by alterations in the lamina propria, extracellular matrix remodeling, and reduced tissue viscoelasticity, contributing to presbyphonia. Ferroptosis, an iron‐dependent form of regulated cell death driven by lipid peroxidation, is increasingly implicated in tissue aging. This study investigated the association between ferroptosis and vocal fold aging using ferrostatin‐1 (Fer‐1) in a rat model. Methods: Thirty‐six male Sprague–Dawley rats were assigned to three groups: Young, Old, and Old–Fer. Fer‐1 (2.5 μmol/kg, 20 μL) was injected unilaterally into the left vocal fold at Weeks 0 and 2. At Week 3, vocal folds were harvested for histological, immunohistochemical, and biochemical analyses. Outcome measures included ferroptosis‐related markers, lamina propria thickness, extracellular matrix morphology, collagen and hyaluronic acid distribution, and inflammatory cytokines. Results: Compared with the Young group, the Old group showed increased lipid peroxidation, reactive oxygen species, and iron accumulation with reduced glutathione peroxidase 4 activity; these changes were attenuated in the Old–Fer group. The Old group also exhibited increased lamina propria thickness, enhanced collagen deposition, and reduced hyaluronic acid distribution, whereas the Old–Fer group demonstrated reduced collagen accumulation and preserved hyaluronic acid distribution. Transforming growth factor‐β and interleukin‐1β expression levels were elevated in the Old group and reduced following Fer‐1 treatment. Conclusion: The results indicate that ferroptosis is involved in vocal fold aging. In addition, Fer‐1 effectively suppressed ferroptotic pathways, which may be associated with the attenuation of aging‐related extracellular matrix alterations in the vocal folds. Level of Evidence: NA.
- 29 June 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (11) , 4981-4990
Open AccessEffects of Ferrostatin‐1 on Vocal Folds in Aging Rats
Objective: Age‐related vocal fold degeneration is characterized by alterations in the lamina propria, extracellular matrix remodeling, and reduced tissue viscoelasticity, contributing to presbyphonia. Ferroptosis, an iron‐dependent form of regulated cell death driven by lipid peroxidation, is increasingly implicated in tissue aging. This study investigated the association between ferroptosis and vocal fold aging using ferrostatin‐1 (Fer‐1) in a rat model. Methods: Thirty‐six male Sprague–Dawley rats were assigned to three groups: Young, Old, and Old–Fer. Fer‐1 (2.5 μmol/kg, 20 μL) was injected unilaterally into the left vocal fold at Weeks 0 and 2. At Week 3, vocal folds were harvested for histological, immunohistochemical, and biochemical analyses. Outcome measures included ferroptosis‐related markers, lamina propria thickness, extracellular matrix morphology, collagen and hyaluronic acid distribution, and inflammatory cytokines. Results: Compared with the Young group, the Old group showed increased lipid peroxidation, reactive oxygen species, and iron accumulation with reduced glutathione peroxidase 4 activity; these changes were attenuated in the Old–Fer group. The Old group also exhibited increased lamina propria thickness, enhanced collagen deposition, and reduced hyaluronic acid distribution, whereas the Old–Fer group demonstrated reduced collagen accumulation and preserved hyaluronic acid distribution. Transforming growth factor‐β and interleukin‐1β expression levels were elevated in the Old group and reduced following Fer‐1 treatment. Conclusion: The results indicate that ferroptosis is involved in vocal fold aging. In addition, Fer‐1 effectively suppressed ferroptotic pathways, which may be associated with the attenuation of aging‐related extracellular matrix alterations in the vocal folds. Level of Evidence: NA.
- Open Access
- 4 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 514
Targeting Ferroptosis to Restore Salivary Gland Homeostasis in an Obesity Model
Obesity is a systemic metabolic disorder that is known to impair various organ systems; however, its precise impact on salivary gland homeostasis remains unclear. Recent studies have implicated ferroptosis—an iron-dependent form of regulated cell death characterized by lipid peroxidation and oxidative stress—in glandular dysfunction. In this study, we used leptin-deficient (ob/ob) mice to elucidate the role of ferroptosis in obesity-associated salivary gland pathology. The protective effects of ferroptosis inhibition were evaluated by administering ferrostatin-1 (a lipid reactive oxygen species [ROS] scavenger) and deferoxamine (an iron chelator) for an 8-week period. Obese mice exhibited significantly increased body weight, food intake, and hyperglycemia. These systemic changes are accompanied by profound histological alterations in the salivary glands, including lipid droplet accumulation, acinar atrophy, and mitochondrial ultrastructural damage. These alterations correlate with the hallmarks of ferroptotic injury, including increased ROS levels (p < 0.001), elevated malondialdehyde levels (p < 0.01), suppressed glutathione peroxidase 4 activity (p < 0.01), and iron overload (p < 0.001). Salivary gland fibrosis, inflammation, and secretory dysfunction were evident, characterized by the upregulation of TGF-β (p < 0.01) and Collagen I (p < 0.05), reduced expression of aquaporin-5 and amylase, and dysregulated levels of autophagy-related markers (LC3B and p62). Treatment with either ferrostatin-1 or deferoxamine significantly mitigated these pathologies; however, the degree of efficacy varied depending on the specific parameters that were examined. Thus, our findings implicate ferroptosis as a critical contributor to salivary gland dysfunction in obesity and suggest that pharmacological inhibition of this pathway represents a viable therapeutic strategy for preserving glandular integrity under metabolic stress.
- 4 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 514
Open AccessTargeting Ferroptosis to Restore Salivary Gland Homeostasis in an Obesity Model
Obesity is a systemic metabolic disorder that is known to impair various organ systems; however, its precise impact on salivary gland homeostasis remains unclear. Recent studies have implicated ferroptosis—an iron-dependent form of regulated cell death characterized by lipid peroxidation and oxidative stress—in glandular dysfunction. In this study, we used leptin-deficient (ob/ob) mice to elucidate the role of ferroptosis in obesity-associated salivary gland pathology. The protective effects of ferroptosis inhibition were evaluated by administering ferrostatin-1 (a lipid reactive oxygen species [ROS] scavenger) and deferoxamine (an iron chelator) for an 8-week period. Obese mice exhibited significantly increased body weight, food intake, and hyperglycemia. These systemic changes are accompanied by profound histological alterations in the salivary glands, including lipid droplet accumulation, acinar atrophy, and mitochondrial ultrastructural damage. These alterations correlate with the hallmarks of ferroptotic injury, including increased ROS levels (p < 0.001), elevated malondialdehyde levels (p < 0.01), suppressed glutathione peroxidase 4 activity (p < 0.01), and iron overload (p < 0.001). Salivary gland fibrosis, inflammation, and secretory dysfunction were evident, characterized by the upregulation of TGF-β (p < 0.01) and Collagen I (p < 0.05), reduced expression of aquaporin-5 and amylase, and dysregulated levels of autophagy-related markers (LC3B and p62). Treatment with either ferrostatin-1 or deferoxamine significantly mitigated these pathologies; however, the degree of efficacy varied depending on the specific parameters that were examined. Thus, our findings implicate ferroptosis as a critical contributor to salivary gland dysfunction in obesity and suggest that pharmacological inhibition of this pathway represents a viable therapeutic strategy for preserving glandular integrity under metabolic stress.
- Open Access
- 1 January 2026
- Published by AME Publishing Company in Gland Surgery
- Vol. 15 (1) , 21
Prognostic value of subthreshold biphasic electromyographic (EMG) waveforms in Type I loss of signal during thyroid intraoperative neuromonitoring
Background: During intraoperative neuromonitoring (IONM), an evoked amplitude below 100 µV is typically regarded as loss of signal (LOS). However, after adjusting the event threshold, previously undetectable electromyographic (EMG) waveforms may become visible. This study aimed to evaluate the diagnostic and clinical significance of such subthreshold EMG waveforms. Methods: A total of 231 patients (335 nerves at risk, NARs) who underwent thyroidectomy with IONM using either EMG endotracheal tube electrodes or adhesive skin electrodes were retrospectively reviewed. Evoked EMG parameters, including mean amplitude and latency after stimulation of the recurrent laryngeal nerve (RLN) and vagus nerve (VN), were analyzed. Preoperative and postoperative laryngoscopic examinations were performed to assess vocal fold mobility. Results: Among the 335 NARs, twelve NARs (3.5%) demonstrated evoked EMG amplitudes below 100 µV and were confirmed as true LOS, all of which were classified as Type I (segmental) LOS. After stepwise lowering the event threshold from 100 µV to 80 and subsequently to 50 µV, biphasic EMG waveforms became detectable in 10 of these 12 cases. Although all 12 nerves exhibited immediate postoperative vocal fold paralysis, the 10 nerves with detectable low-amplitude waveforms showed complete recovery of vocal fold mobility within eight months postoperatively. Conclusions: In cases of Type I LOS during thyroid surgery, the presence of subthreshold biphasic EMG waveforms may reflect residual neural conduction and is strongly associated with postoperative vocal fold recovery. These findings suggest that optimization of threshold settings can improve the sensitivity of IONM interpretation and assist in intraoperative prognostic assessment.
- 1 January 2026
- Published by AME Publishing Company in Gland Surgery
- Vol. 15 (1) , 21
Open AccessPrognostic value of subthreshold biphasic electromyographic (EMG) waveforms in Type I loss of signal during thyroid intraoperative neuromonitoring
Background: During intraoperative neuromonitoring (IONM), an evoked amplitude below 100 µV is typically regarded as loss of signal (LOS). However, after adjusting the event threshold, previously undetectable electromyographic (EMG) waveforms may become visible. This study aimed to evaluate the diagnostic and clinical significance of such subthreshold EMG waveforms. Methods: A total of 231 patients (335 nerves at risk, NARs) who underwent thyroidectomy with IONM using either EMG endotracheal tube electrodes or adhesive skin electrodes were retrospectively reviewed. Evoked EMG parameters, including mean amplitude and latency after stimulation of the recurrent laryngeal nerve (RLN) and vagus nerve (VN), were analyzed. Preoperative and postoperative laryngoscopic examinations were performed to assess vocal fold mobility. Results: Among the 335 NARs, twelve NARs (3.5%) demonstrated evoked EMG amplitudes below 100 µV and were confirmed as true LOS, all of which were classified as Type I (segmental) LOS. After stepwise lowering the event threshold from 100 µV to 80 and subsequently to 50 µV, biphasic EMG waveforms became detectable in 10 of these 12 cases. Although all 12 nerves exhibited immediate postoperative vocal fold paralysis, the 10 nerves with detectable low-amplitude waveforms showed complete recovery of vocal fold mobility within eight months postoperatively. Conclusions: In cases of Type I LOS during thyroid surgery, the presence of subthreshold biphasic EMG waveforms may reflect residual neural conduction and is strongly associated with postoperative vocal fold recovery. These findings suggest that optimization of threshold settings can improve the sensitivity of IONM interpretation and assist in intraoperative prognostic assessment.
- Open Access
- 31 December 2025
- Published by The Busan, Ulsan, Gyeoungnam Branch of The Korean Society of Otolaryngology in Journal of Clinical Otolaryngology
- Vol. 36 (4) , 97-101
2 Cases of Stapler-Assisted Pharyngeal Closure in Total Laryngectomy
- 31 December 2025
- Published by The Busan, Ulsan, Gyeoungnam Branch of The Korean Society of Otolaryngology in Journal of Clinical Otolaryngology
- Vol. 36 (4) , 97-101
Open Access2 Cases of Stapler-Assisted Pharyngeal Closure in Total Laryngectomy
- Open Access
- 12 December 2025
- Published by MDPI AG in Preprints.org
Targeting Ferroptosis to Restore Salivary Gland Homeostasis in an Obesity Model
Obesity is a systemic metabolic disorder that is known to impair various organ systems; however, its precise impact on salivary gland homeostasis remains unclear. Recent studies have implicated ferroptosis—an iron-dependent form of regulated cell death characterized by lipid peroxidation and oxidative stress—in glandular dysfunction. In this study, we used leptin-deficient (ob/ob) mice to elucidate the role of ferroptosis in obesity-associated salivary gland pathology. The protective effects of ferroptosis in-hibition were evaluated by administering ferrostatin-1 (a lipid reactive oxygen species [ROS] scavenger) and deferoxamine (an iron chelator) for an 8-week period. Obese mice exhibited significantly increased body weight, food intake, and hyperglycemia. These systemic changes are accompanied by profound histological alterations in the salivary glands, including lipid droplet ac-cumulation, acinar atrophy, and mitochondrial ultrastructural damage. These alterations correlate with the hallmarks of ferrop-totic injury, including increased ROS levels, elevated malondialdehyde levels, suppressed glutathione peroxidase 4 activity, and iron overload. Salivary gland fibrosis, inflammation, and secretory dysfunction were evident, characterized by the upregulation of TGF-β and Collagen I, reduced expression of aquaporin-5 and amylase, and dysregulated levels of autophagy-related markers (LC3B and p62). Treatment with either ferrostatin-1 or deferoxamine significantly mitigated these pathologies; however, the degree of efficacy varied depending on the specific parameters that were examined. Thus, our findings implicate ferroptosis is a critical contributor to salivary gland dysfunction in obesity, and suggest that pharmacological inhibition of this pathway repre-sents a viable therapeutic strategy for preserving glandular integrity under metabolic stress.
- 12 December 2025
- Published by MDPI AG in Preprints.org
Open AccessTargeting Ferroptosis to Restore Salivary Gland Homeostasis in an Obesity Model
Obesity is a systemic metabolic disorder that is known to impair various organ systems; however, its precise impact on salivary gland homeostasis remains unclear. Recent studies have implicated ferroptosis—an iron-dependent form of regulated cell death characterized by lipid peroxidation and oxidative stress—in glandular dysfunction. In this study, we used leptin-deficient (ob/ob) mice to elucidate the role of ferroptosis in obesity-associated salivary gland pathology. The protective effects of ferroptosis in-hibition were evaluated by administering ferrostatin-1 (a lipid reactive oxygen species [ROS] scavenger) and deferoxamine (an iron chelator) for an 8-week period. Obese mice exhibited significantly increased body weight, food intake, and hyperglycemia. These systemic changes are accompanied by profound histological alterations in the salivary glands, including lipid droplet ac-cumulation, acinar atrophy, and mitochondrial ultrastructural damage. These alterations correlate with the hallmarks of ferrop-totic injury, including increased ROS levels, elevated malondialdehyde levels, suppressed glutathione peroxidase 4 activity, and iron overload. Salivary gland fibrosis, inflammation, and secretory dysfunction were evident, characterized by the upregulation of TGF-β and Collagen I, reduced expression of aquaporin-5 and amylase, and dysregulated levels of autophagy-related markers (LC3B and p62). Treatment with either ferrostatin-1 or deferoxamine significantly mitigated these pathologies; however, the degree of efficacy varied depending on the specific parameters that were examined. Thus, our findings implicate ferroptosis is a critical contributor to salivary gland dysfunction in obesity, and suggest that pharmacological inhibition of this pathway repre-sents a viable therapeutic strategy for preserving glandular integrity under metabolic stress.
- Open Access
- 10 April 2025
- Published by SAGE Publications in Ear, Nose & Throat Journal
Multiple Congenital Cholesteatoma: The Risk of Missing the Other One
- 10 April 2025
- Published by SAGE Publications in Ear, Nose & Throat Journal
Open AccessMultiple Congenital Cholesteatoma: The Risk of Missing the Other One
- Open Access
- 31 March 2025
- Published by The Busan, Ulsan, Gyeoungnam Branch of The Korean Society of Otolaryngology in Journal of Clinical Otolaryngology
- Vol. 36 (1) , 3-7
Removal of Squamous Cell Carcinoma in Helical Rim and its Reconstruction
임상이비인후과(Journal of Clinical Otolaryngology Head and Neck Surgery)
- 31 March 2025
- Published by The Busan, Ulsan, Gyeoungnam Branch of The Korean Society of Otolaryngology in Journal of Clinical Otolaryngology
- Vol. 36 (1) , 3-7
Open AccessRemoval of Squamous Cell Carcinoma in Helical Rim and its Reconstruction
임상이비인후과(Journal of Clinical Otolaryngology Head and Neck Surgery)
- Open Access
- 1 March 2025
- Published by AME Publishing Company in Gland Surgery
- Vol. 14 (3) , 305-316
Preoperative localization of single gland disease in primary hyperparathyroidism: a comparative study for preoperative localization with four-dimensional computed tomography, ultrasonography, and technetium-99m-sestamibi single-photon emission computed tomography
Background: Treatment guidelines for primary hyperparathyroidism (PHPT) recommend high-resolution neck ultrasonography (US), technetium-99m-sestamibi single-photon emission computed tomography (99mTc-sestamibi SPECT), and contrast-enhanced four-dimensional computed tomography (4D CT) as image evaluation methods. This study aimed to compare the sensitivity and accuracy of the three image evaluation methods recommended in the guidelines for patients with PHPT and evaluate the utility of 4D CT for preoperative localization in single gland disease. Methods: A retrospective medical chart review was performed on 41 patients who underwent surgery for single gland disease at the Department of Otorhinolaryngology, Pusan National University Hospital, between January 2021 and March 2023. All the patients underwent preoperative US, 99mTc-sestamibi SPECT, and 4D CT. The location of the abnormal parathyroid lesion, removed during surgery and confirmed by postoperative pathological examination, was used as the reference standard. The sensitivity, specificity, and accuracy of the three imaging evaluations were assessed and compared to the reference standard location. Results: The sensitivity, specificity, and accuracy of the imaging modalities were as follows: 4D CT, 95.1%, 98.4%, and 97.6%; US, 82.9%, 95.1%, and 92.1%; and 99mTc-sestamibi SPECT, 78.0%, 97.6%, and 92.7%, respectively. Furthermore, a total of nine cases were identified where accurate localization could not be achieved through US and 99mTc-sestamibi SPECT. The presence of coexisting thyroid lesions was significantly correlated with incorrect localization in preoperative US (P99mTc-sestamibi SPECT (PConclusions: In the preoperative localization of abnormal parathyroid lesions, 4D CT demonstrated higher sensitivity and specificity than US and 99mTc-sestamibi SPECT. 4D CT can accurately localize abnormal parathyroid lesions, even in cases in which both US and 99mTc-sestamibi SPECT yielded incorrect localizations.
- 1 March 2025
- Published by AME Publishing Company in Gland Surgery
- Vol. 14 (3) , 305-316
Open AccessPreoperative localization of single gland disease in primary hyperparathyroidism: a comparative study for preoperative localization with four-dimensional computed tomography, ultrasonography, and technetium-99m-sestamibi single-photon emission computed tomography
Background: Treatment guidelines for primary hyperparathyroidism (PHPT) recommend high-resolution neck ultrasonography (US), technetium-99m-sestamibi single-photon emission computed tomography (99mTc-sestamibi SPECT), and contrast-enhanced four-dimensional computed tomography (4D CT) as image evaluation methods. This study aimed to compare the sensitivity and accuracy of the three image evaluation methods recommended in the guidelines for patients with PHPT and evaluate the utility of 4D CT for preoperative localization in single gland disease. Methods: A retrospective medical chart review was performed on 41 patients who underwent surgery for single gland disease at the Department of Otorhinolaryngology, Pusan National University Hospital, between January 2021 and March 2023. All the patients underwent preoperative US, 99mTc-sestamibi SPECT, and 4D CT. The location of the abnormal parathyroid lesion, removed during surgery and confirmed by postoperative pathological examination, was used as the reference standard. The sensitivity, specificity, and accuracy of the three imaging evaluations were assessed and compared to the reference standard location. Results: The sensitivity, specificity, and accuracy of the imaging modalities were as follows: 4D CT, 95.1%, 98.4%, and 97.6%; US, 82.9%, 95.1%, and 92.1%; and 99mTc-sestamibi SPECT, 78.0%, 97.6%, and 92.7%, respectively. Furthermore, a total of nine cases were identified where accurate localization could not be achieved through US and 99mTc-sestamibi SPECT. The presence of coexisting thyroid lesions was significantly correlated with incorrect localization in preoperative US (P99mTc-sestamibi SPECT (PConclusions: In the preoperative localization of abnormal parathyroid lesions, 4D CT demonstrated higher sensitivity and specificity than US and 99mTc-sestamibi SPECT. 4D CT can accurately localize abnormal parathyroid lesions, even in cases in which both US and 99mTc-sestamibi SPECT yielded incorrect localizations.
- Open Access
- 21 October 2023
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
- Vol. 66 (10) , 646-654
Clinical Characteristics Associated With Re-Insertion and Postoperative Complication of Ventilation Tube Insertion in Pediatric Patients
Background and Objectives Otitis media with effusion is a common disease in the pediatric population. When medical treatment fails, ventilation tube insertion (VTI) is the best treatment choice. In this article, we aimed to analyze complications following VTI and evaluate clinical characteristics that increase the possibility of reoperation.Subjects and Method This study retrospective reviewed the medical charts of 287 pediatric patients who underwent VTI in our institute from May 2015 to June 2020. Patients were classified into two groups: the single VTI group, who were operated on once, and the multiple VTI group, who were operated on at least twice. We studied the differences between the two groups regarding patient demographics, the operative method, operative-related data, treatment outcomes, and complications.Results Our study included 181 patients (308 ears), consisting of 114 males (63.0%) and 67 females (37.0%). Among the patients, 141 patients (237 ears) were included in the single VTI group, and 40 patients (71 ears) were included in the multiple VTI group. There was a higher tendency of re-operation for patients whose age was younger at the first operation than for older patients and for those who had underlying diseases such as genetic diseases, developmental delay or language delay. We also found that the retraction state of the tympanic membrane after tube extrusion and earlier extrusion or obstruction of the ventilation tube was statistically significant factors associated with reoperation.Conclusion Our study identified factors affecting the possibility of reoperation. Regular follow-ups are necessary if these factors are present.
- 21 October 2023
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
- Vol. 66 (10) , 646-654
Open AccessClinical Characteristics Associated With Re-Insertion and Postoperative Complication of Ventilation Tube Insertion in Pediatric Patients
Background and Objectives Otitis media with effusion is a common disease in the pediatric population. When medical treatment fails, ventilation tube insertion (VTI) is the best treatment choice. In this article, we aimed to analyze complications following VTI and evaluate clinical characteristics that increase the possibility of reoperation.Subjects and Method This study retrospective reviewed the medical charts of 287 pediatric patients who underwent VTI in our institute from May 2015 to June 2020. Patients were classified into two groups: the single VTI group, who were operated on once, and the multiple VTI group, who were operated on at least twice. We studied the differences between the two groups regarding patient demographics, the operative method, operative-related data, treatment outcomes, and complications.Results Our study included 181 patients (308 ears), consisting of 114 males (63.0%) and 67 females (37.0%). Among the patients, 141 patients (237 ears) were included in the single VTI group, and 40 patients (71 ears) were included in the multiple VTI group. There was a higher tendency of re-operation for patients whose age was younger at the first operation than for older patients and for those who had underlying diseases such as genetic diseases, developmental delay or language delay. We also found that the retraction state of the tympanic membrane after tube extrusion and earlier extrusion or obstruction of the ventilation tube was statistically significant factors associated with reoperation.Conclusion Our study identified factors affecting the possibility of reoperation. Regular follow-ups are necessary if these factors are present.